Zhu Jiayu, Luo Shengping, Yu Fei, Sun Kewei
The First Clinical College of Chinese Medicine, Hunan University of Chinese Medicine, Changsha, China.
School of Integrated Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha, China.
Front Immunol. 2025 May 2;16:1549600. doi: 10.3389/fimmu.2025.1549600. eCollection 2025.
OBJECTIVE: The purpose of this study was to analyze the research hotspots and future trends in the field of ferroptosis in hepatocellular carcinoma in the past 10 years by using bibliometrics and visualization software, and to provide reference for future research directions in this field. METHODS: The Web of Science database was searched from January 1, 2012, to October 30, 2024, and the annual publication volume, countries, institutions, journals, authors, references, keywords, and other information in this field were analyzed by bibliometrics, VOSviewer, and CiteSpace. RESULTS: A total of 645 English articles from 729 institutions in 32 countries were included in this study, with 4545 authors published in 261 journals. In the past three years, 518 articles were published, accounting for 80.3%. China has the most publications, followed by the United States. Frontiers in Oncology had the highest number of papers (n=26), while Cell had the highest number of citations (n=1206). The current research mainly focuses on two aspects: one is the study of the mechanism of ferroptosis to explore new therapeutic targets, and the other is the exploration of therapeutic methods, such as photodynamic therapy and nanomaterials, in order to inhibit the proliferation of tumor cells, reduce drug resistance, and enhance the efficacy by regulating ferroptosis, which may become a future development trend. CONCLUSION: In recent years, there have been increasing studies on the association between ferroptosis and hepatocellular carcinoma. This is the first comprehensive bibliometric study, which provides a reliable reference for future research in this field and promotes its further development.
目的:本研究旨在运用文献计量学和可视化软件分析过去10年肝细胞癌中铁死亡领域的研究热点和未来趋势,为该领域未来的研究方向提供参考。 方法:检索2012年1月1日至2024年10月30日的Web of Science数据库,通过文献计量学、VOSviewer和CiteSpace分析该领域的年度发文量、国家、机构、期刊、作者、参考文献、关键词等信息。 结果:本研究共纳入来自32个国家729个机构的645篇英文文章,有4545位作者发表在261种期刊上。在过去三年中发表了518篇文章,占80.3%。中国的发文量最多,其次是美国。《肿瘤前沿》的论文数量最多(n = 26),而《细胞》的被引次数最高(n = 1206)。当前的研究主要集中在两个方面:一是铁死亡机制的研究以探索新的治疗靶点,二是探索光动力疗法和纳米材料等治疗方法,以通过调节铁死亡来抑制肿瘤细胞增殖、降低耐药性并提高疗效,这可能成为未来的发展趋势。 结论:近年来,关于铁死亡与肝细胞癌之间关联的研究不断增加。这是第一项全面的文献计量学研究,为该领域未来的研究提供了可靠的参考,并促进其进一步发展。
Front Immunol. 2023
BMC Cancer. 2025-3-21
World J Gastrointest Oncol. 2025-3-15